According to GlobalData, BIOLOX DELTA is one of 431 product lines sold in the US hip reconstruction market; these product lines are sold by 35 different manufacturers. The average selling price for BIOLOX DELTA decreased in hospitals, increased in health systems, and increased outside of hospital facilities in 2022. The price of the BIOLOX DELTA device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as United Orthopedic apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

United Orthopedic overview

United Orthopedic Corp (UOC) is a medical device company. It designs, manufactures and distributes orthopedic implants and instrument sets. The company provides product categories such as knee replacement systems, hip replacement systems, and oncology products, among others. It offers hip replacement systems such as UCP stem, UTF reduced stem, U2 HA stem, U2 matrix porous stem, U2 revision stem, bipolar II system, U2 cemented stem, full XPE cup, revision femoral head, GTF II stem, BIOLOX option, and RepliCase hip, among others. UOC provides clinical education, service and support for surgeons and hospital. The company markets its products in Italy, Turkey, Spain, Iran, Greece, South Africa, Thailand and Puerto Rico. It operates in China and the US. UOC is headquartered in New Taipei, Taiwan.

For a complete picture of BIOLOX DELTA, Hip Reconstruction pricing in the US, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.